Rapid delivery of toxicological material
Drug Target Review
SEPTEMBER 10, 2024
The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. Therefore, there would be almost no appetite for trying to justify a change in formulation between Tox and clinical supplies.
64 
Let's personalize your content